Current filters:  
Saudi Arabia
Healthcare
Saudi Arabia
Goodwin Procter LLP
On January 24, Alvotech and Bioventure, a subsidiary of GlobalOne Healthcare Holding LLC, announced that the Saudi Food & Drug Authority has approved SIMLANDI...
United Trademark & Patent Services
The Saudi Food and Drug Authority (SFDA) is an independent regulator of foods, drugs and medical devices in the Kingdom. A major function of the SFDA is to issue national standards and set mandatory standard specifications...
STA Law Firm
The Saudi 2030 Vision promotes cutting-edge technology in health services for benefit of all the citizen in Kingdom of Saudi Arabia (KSA).
Clyde & Co
The Saudi Council of Ministers has recently approved certain amendments to the Private Health Institutes Law (the Amendments).
Al Tamimi & Company
In a recent case the Dubai Public Prosecution (‘DPP') charged a medical practitioner with malpractice.
Clyde & Co
The Council of Cooperative Health Insurance issued a circular on 22 July 2018 addressed to all health insurers, healthcare providers and TPAs that a new claims settlement process will come into effect in October 2018.
Al Tamimi & Company
Effective 22 January 2018, the Ministry of Health and Prevention in the United Arab Emirates (‘MOHAP') issued a Ministerial Resolution that provides for the fast-track registration of...
Al Tamimi & Company
Establishing a hospital in the MENA region or investing into an existing medical facility is of significant interest for investors globally.
Al Tamimi & Company
In an era where picture-perfect images of flawless men and women flash before our eyes constantly, the pressure of maintaining a perfect appearance is mounting in our society.
Al Tamimi & Company
A relatively new regulation has been introduced in Jordan, which is the Regulation for Licensing Home Healthcare Institutions No. 84 of 2016 (the ‘Regulation').
Al Tamimi & Company
Saudi Arabia's ambitious programme of social and economic renewal, Vision 2030 (announced in April 2016), has healthcare squarely in its sights.
Al Tamimi & Company
For the pharmaceutical industry and for governmental regulators, counterfeit medications remain a top concern not only in the MENA region, but globally.
Shearman & Sterling LLP
Reform of how public healthcare and related services are delivered in the Kingdom is one of the Government's most important priorities.
Clyde & Co
It is known that SAGIA towards the end of 2016 and earlier on 2017 has started issuing trading license to a number of international pharmaceutical companies through a 100% structure or Joint Venture.
Shearman & Sterling LLP
The Kingdom of Saudi Arabia is widely recognised as having the largest and fastest growing population in the Gulf Cooperation Council (the "GCC"), with over half the population under 40.
Clyde & Co
Other human healthcare services CPC 9319 except CPC 93191" and excluding of course the services listed under the Negative List.
Al Tamimi & Company
The sensitive subject-matter of how to determine the best course of action with regard to the treatment, or other options, for a patient who is reaching the end of their life, who may be terminally ill...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media